Arkolith/Insider Trading/ATTO/Form 4

Redmile Group, LLC

10% OwnerAttovia Therapeutics, Inc. (ATTO) · full profile →Form 4 · filed Aug 8, 2026
Net Buying
Open-Market Buys
$10.2M
Open-Market Sells
$0
Net Open-Market Flow
$10.2M
Transactions
4
3 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Aug 6, 2026Conversion(C)783K——783K
Aug 6, 2026Buy(P)200K$17.00$3.4M983K
Aug 6, 2026Buy(P)400K$17.00$6.8M1.2M

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Aug 6, 2026Conversion(C)783K——0

Transaction Codes

C
Conversion of a derivative
P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-26-092867) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML

Keep exploring

Connected pages for Attovia Therapeutics, Inc.

Build

Build on these Form 4 transactions

The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.

Form 4 insider API

Open-market buys and sells, cluster scans, company flows.

insider.transactions

13F holdings API

Owners, holdings, deltas, point-in-time portfolios.

stock.owners

MCP quickstart

Connect an agent, mint a key, make the first call.

/api/mcp